Clinical trial
Impact of Postnatal Betamethasone Treatment on Closure of Ductus Arteriosus in Preterm Infants
NCT05987202 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Postnatal Betamethasone Treatment on Closure of Ductus Arteriosus in Preterm Infants
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2023
- Completion date
- December 1, 2024
- Enrollment
- 51 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
persistent ductus arteriosus